Patents Assigned to BAYER AS
  • Patent number: 11884643
    Abstract: The present disclosure relates to thienyloxazolones and analogues thereof of formula (III) that may be used for protecting plants from bacterial diseases, in particular from bacterial diseases caused by bacteria belonging to the genus Xanthomonas.
    Type: Grant
    Filed: July 3, 2019
    Date of Patent: January 30, 2024
    Assignee: Bayer Aktiengesellschaft
    Inventors: David Bernier, Stéphane Brunet, Jérémy Dufour, Thomas Knobloch, Lionel Nicolas, Tomoki Tsuchiya
  • Publication number: 20240016152
    Abstract: The present invention relates to active compound combinations, in particular within a fungicide composition, which comprise as compound (A) a compound of formula (I) and as compound (B) a further fungicidally active compound as specified below. Moreover, the invention relates to compositions comprising such compound combination and to the use of the compound combinations and the fungicide compositions as biologically active agent, especially for control of phytopathogenic fungi in crop protection and in the protection of industrial materials and as plant growth regulators.
    Type: Application
    Filed: June 16, 2021
    Publication date: January 18, 2024
    Applicant: Bayer Aktiengesellschaft
    Inventors: Agostinos Michael KLÜKEN, Julie GEIST, Cyril MONTAGNE, Anthony MILLET, Lionel NICOLAS, Tomoki TSUCHIYA
  • Patent number: 11872155
    Abstract: The present invention relates to an inserter for an intrauterine system comprising a handle (3), and an insertion tube (6) having a first end and a second end, and being arranged in connection with the handle. The inserter is characterized in that the first end of the insertion tube (6) comprises at least one frame slot for receiving a frame of the intrauterine system. The invention also relates to a kit comprising an inserter according to the present invention and an intrauterine system, wherein the intrauterine system (1) comprises a therapeutic component (1b) and a continuous, closed frame (1a), the therapeutic component (1b) being connected to the frame (1a) at least one point, and therapeutic component (1b) of the intrauterine system (1) is at least mainly arranged inside the first end of the insertion tube (6) and the frame (1a) of the intrauterine system (1) is at least mainly arranged outside the first end of the insertion tube (6).
    Type: Grant
    Filed: February 17, 2020
    Date of Patent: January 16, 2024
    Assignee: Bayer Oy
    Inventors: Heikki Lyytikäinen, Ilkka Jutila, Ulla Calvo Alonso, Harri Jukarainen, Taina Träder, Andrew MacLeod, Michael Noble, David Whitaker
  • Patent number: 11865323
    Abstract: A fluid injection system and a fluid verification system for confirming that a syringe, containing a fluid for injection, is fully filled with fluid and neither has free space (i.e., air) near the distal end thereof when the syringe is provided in an upright position nor contains air bubbles. Imaging processing techniques and systems are also provided to determine various injection parameters and to verify the type and certain properties of fluid that is present within a syringe.
    Type: Grant
    Filed: February 18, 2021
    Date of Patent: January 9, 2024
    Assignee: BAYER HEALTHCARE LLC
    Inventors: Kevin Cowan, Michael Spohn, Michael McDermott
  • Patent number: 11864557
    Abstract: The present invention relates to novel heteroaryl-triazole and heteroaryl-tetrazole compounds of the general formula (I), in which the structural elements Y, Q1, Q2, R1, R2, R3, R4 and R5 have the meaning given in the description, to formulations and compositions comprising such compounds and for their use in the control of animal pests including arthropods and insects in plant protection and to their use for control of ectoparasites on animals.
    Type: Grant
    Filed: September 29, 2022
    Date of Patent: January 9, 2024
    Assignee: BAYER AKTIENGESELLSCHAFT
    Inventors: Alexander Arlt, Werner Hallenbach, Hans-Georg Schwarz, Martin Fuesslein, Heinz-Juergen Wroblowsky, Estella Buscato Arsequell, Marc Linka, Kerstin Ilg, Arunas Jonas Damijonaitis, Ulrich Ebbinghaus-Kintscher, Ulrich Goergens, Yolanda Cancho Grande, Peter Jeschke, Joachim Telser, Iring Heisler, Andreas Turberg
  • Patent number: 11865294
    Abstract: A fluid control valve for use in a fluid delivery system for delivering fluid to a patient includes a valve body defining an internal chamber, a first inlet port for receiving a first inlet tube, a second inlet port for receiving a second inlet tube, an outlet port, and a sliding valve member slidably disposed in the internal chamber. The first inlet tube defines a first inlet lumen axially aligned with the internal chamber. The second inlet tube defines a second inlet lumen axially aligned with the internal chamber. The sliding valve member includes a first sealing end and second sealing end. The sliding valve member is positionable in a first operating state, a second operating state, and a third operating state based on a flow differential between the first inlet lumen and the second inlet lumen.
    Type: Grant
    Filed: October 16, 2017
    Date of Patent: January 9, 2024
    Assignee: BAYER HEALTHCARE LLC
    Inventors: Michael Spohn, Kevin Cowan, Brian Cain, David Berry, James Fentress, David Orenstein, James Dedig, Barry Tucker
  • Publication number: 20240000767
    Abstract: The present invention relates to a combination of selective blockers of TASK-1 and TASK-3 channels, in particular substituted imidazo [1,2-a]pyrimidine and substituted imidazo [1,2-a]pyridine derivatives of formula (II) and ?2-Adrenoceptor subtype C (alpha-2C) antagonists, in particular substituted heterocyclic carboxamides of formula (I) for the treatment and/or prophylaxis of sleep-related breathing disorders, preferably obstructive and central sleep apneas and snoring.
    Type: Application
    Filed: July 5, 2021
    Publication date: January 4, 2024
    Applicant: Bayer Aktiengesellschaft
    Inventors: Martina DELBECK, Michael HAHN
  • Publication number: 20240005650
    Abstract: Systems, methods, and computer programs disclosed herein relate to training of machine learning models on the basis of image training data with a limited number of labeled images.
    Type: Application
    Filed: November 12, 2021
    Publication date: January 4, 2024
    Applicant: Bayer Aktiengesellschaft
    Inventors: Jonas DIPPEL, Steffen VOGLER, Johannes HÖHNE
  • Patent number: 11857684
    Abstract: The present disclosure relates generally to bilayer tablets comprising a combination of two active pharmaceutical ingredients, and more specifically to bilayer tablets comprising acetylsalicylic acid, pseudoephedrine, and a dissolution aid. The bilayer tablets utilize a combination of granulated and non-granulated acetylsalicylic acid along with a unique distribution of sodium carbonate as a dissolution aid that provide acetylsalicylic acid and pseudoephedrine in a single dosage form having rapid dissolution and long-term storage stability (low degradation). The present disclosure also provides methods of preparing and of using the bilayer tablets.
    Type: Grant
    Filed: November 11, 2021
    Date of Patent: January 2, 2024
    Assignee: Bayer HealthCare LLC
    Inventor: Harsh Mehta
  • Publication number: 20230416249
    Abstract: Compounds of formula (I) processes for their production and their use as pharmaceuticals.
    Type: Application
    Filed: May 10, 2023
    Publication date: December 28, 2023
    Applicants: Bayer Aktiengesellschaft, Bayer Pharma Aktiengesellschaft, The Broad Institute, Inc., Dana-Farber Cancer Institute, Inc.
    Inventors: Stephan SIEGEL, Franziska SIEGEL, Volker SCHULZE, Markus BERGER, Keith GRAHAM, Ulrich KLAR, Jeremie Xavier G. MORTIER, Detlev SÜLZLE, Ulf BÖMER, Daniel KORR, Jens SCHRÖDER, Matthew MEYERSON, Heidi GREULICH, Bethany KAPLAN
  • Patent number: 11850182
    Abstract: The invention relates to an inserter for an intrauterine system, including a handle (3) having a longitudinal opening (8) at its first end, the opening (8) having a longitudinal axis parallel to the longitudinal axis of the inserter, a first end (8a) and a second end (8b), a moveable slider (5) arranged in the longitudinal opening (8) and having a first end (5a) and a second end (5b), a plunger (2) attached to the handle (3), an insertion tube (6) arranged around the plunger (2) having a first end and a second end, with its second end attached to the slider (5). The inserter further includes a lock that reversibly locks locking the intrauterine system in relation to the plunger (2) via a removal string of the intrauterine system, the lock being controllable by the slider (5) and/or the insertion tube (6).
    Type: Grant
    Filed: May 12, 2022
    Date of Patent: December 26, 2023
    Assignee: Bayer Oy
    Inventors: Ilkka Jutila, Heikki Lyytikäinen, Ulla Calvo Alonso, Taina Tjäder, Marjo Ali-Äijälä
  • Patent number: 11849724
    Abstract: The present disclosure relates to the field of agrochemical compositions and formulations. In an aspect, the present disclosure provides for a composition in combination with a fibril or microfibril or nanofibril structuring agent. In yet another aspect, the disclosure provides for a composition comprising: (a) an agricultural bioactive material, a fungicide, insecticide, herbicide, and/or plant growth regulator; (b) a fibril or microfibril or nanofibril structuring agent; and (c) optionally, an auxiliary surface active agent. The disclosure further provides for a comprising a composition described herein mixed or combined with a liquid fertilizer.
    Type: Grant
    Filed: August 15, 2018
    Date of Patent: December 26, 2023
    Assignee: Bayer CropScience LP
    Inventors: Milind Singh, David A. Long, Aveen Alkhatib
  • Publication number: 20230405015
    Abstract: The present invention provides a method of treatment of sarcoma comprising administering to a patient in need thereof a compound of general formula (I), in which R1, R2, R3, and R4, are as defined herein, alone or in pharmaceutical compositions or combinations comprising said compounds as a sole agent or in combination with other active ingredients.
    Type: Application
    Filed: August 31, 2023
    Publication date: December 21, 2023
    Applicants: Bayer Aktiengesellschaft, The Broad Institute, Inc., Dana-Farber Cancer Institute, Inc.
    Inventors: Martin LANGE, Stefan KAULFUSS, Charlotte Christine KOPITZ, Heidi GREULICH, Xiaoyun WU, Matthew MEYERSON
  • Patent number: 11839751
    Abstract: An apparatus (300) for suspending air bubbles in a fluid path of a fluid injector system includes an internal chamber (320) having a curved interior wall (322) defined within the housing (310), an inlet fluid pathway in fluid communication with the internal chamber, and an outlet fluid pathway in fluid communication with the internal chamber. The inlet fluid pathway extending into the chamber at a tangent to the curved interior wall, and the outlet fluid pathway spaced from the inlet fluid pathway such that fluid flowing into the internal chamber via the inlet fluid pathway is directed away from the outlet fluid pathway. The internal chamber is configured to create an internal fluid vortex in an injection fluid entering the internal chamber from the inlet fluid pathway, and wherein the internal fluid vortex at least temporarily suspends air bubbles in the fluid in the internal vortex and delays the passage of the air bubbles to the outlet fluid pathway.
    Type: Grant
    Filed: June 16, 2021
    Date of Patent: December 12, 2023
    Assignee: BAYER HEALTHCARE LLC
    Inventors: Kevin Cowan, James Dedig, Michael Spohn, John Haury
  • Patent number: 11834434
    Abstract: Substituted 2-heteroaryloxypyridines and salts thereof and use thereof as herbicidal active substances Substituted 2-heteroaryloxypyridines of the general formula (I) are described, and their use as herbicides, in particular for controlling broad-leaved weeds and/or weed grasses in crops of useful plants and/or as plant growth regulators for influencing the growth of crops of useful plants. The present invention further relates to herbicidal and/or plant growth-regulating compositions comprising one or more compounds of the general formula (I).
    Type: Grant
    Filed: June 19, 2019
    Date of Patent: December 5, 2023
    Assignee: Bayer Aktiengesellschaft
    Inventors: Michael Charles McLeod, Ralf Braun, Anu Bheemaiah Machettira, Dirk Schmutzler, Elisabeth Asmus, Christopher Hugh Rosinger, Elmar Gatzweiler
  • Patent number: 11825838
    Abstract: The invention relates, inter alia, to compounds of general formula (I). The invention also relates to methods for synthesizing the compounds of formula (I). The compounds according to the invention are in particular suitable for controlling insects, arachnids and nematodes in agricultural applications and for controlling ectoparasites in veterinary medicine.
    Type: Grant
    Filed: March 26, 2018
    Date of Patent: November 28, 2023
    Assignee: Bayer CropScience Aktiengesellschaft
    Inventors: Tobias Harschneck, Alexander Arlt, Robert Velten, Michael Maue, Kerstin Ilg, Werner Hallenbach, Ulrich Goergens, Sebastian Horstmann, Peter Loesel, Andreas Turberg
  • Patent number: 11826541
    Abstract: A cap for intake and delivery of a fluid from a syringe is described. The cap includes an outer cap assembly comprising a fluid inlet path and a fluid outlet path and an inner cap assembly configured for insertion into a fluid nozzle of the syringe and to provide selective fluid communication between an interior of a syringe and the fluid inlet path or the fluid outlet path. The outer cap assembly is slidable relative to the inner cap assembly between a first filling position, where the interior of the syringe is in fluid communication with the fluid inlet path, and a second delivery position, where the interior of the syringe is in fluid communication with the fluid outlet path. Syringes including the cap are also described.
    Type: Grant
    Filed: September 12, 2018
    Date of Patent: November 28, 2023
    Assignee: BAYER HEALTHCARE LLC
    Inventors: Kevin Cowan, Michael Spohn, Barry Tucker, Matthew Walker, James Dedig, James Fentress, Joseph Ranaletta
  • Patent number: 11826553
    Abstract: A fluid injector system for delivering a multi-phase fluid injection to a patient and methods of fluid delivery is disclosed. Methods of creating and using a multi-aspect fluid path impedance model of the injector system are used. Modeling and adjustment of factors that affect impedance and prevent or reduce backflow, reduce the likelihood of fluid flow rate spikes and provide more accurate flow rates and mixing ratios of fluids may be repeated or happen essentially continuously during an injection. The adjustments may be determined before the injection or determined and/or adjusted during the injection. The determination may include sensor feedback commonly used in injectors such as pressure and position feedback as well as other sensors. In all cases, the user can be notified of adjustments through on-screen notices and/or through the recordation of the injection data by a control device of the injector at the conclusion of the injection.
    Type: Grant
    Filed: September 28, 2021
    Date of Patent: November 28, 2023
    Assignee: BAYER HEALTHCARE LLC
    Inventors: Arthur Uber, III, Chelsea Marsh, William Barone, Michael McDermott, Timothy Newing, Michael Spohn, Vince Delbrugge, Ralph Schriver, Kevin Cowan, David Griffiths
  • Patent number: D1011920
    Type: Grant
    Filed: June 5, 2021
    Date of Patent: January 23, 2024
    Assignee: Bayer Consumer Care AG
    Inventors: Pil Ho Chung, Mark Prommel
  • Patent number: D1011921
    Type: Grant
    Filed: June 5, 2021
    Date of Patent: January 23, 2024
    Assignee: Bayer Consumer Care AG
    Inventors: Pil Ho Chung, Mark Prommel